Day: May 31, 2022

THE WOODLANDS, Texas, May 31, 2022 (GLOBE NEWSWIRE) — via InvestorWire — SPYR Technologies [OTCQB: SPYR] (“SPYR” or the “Company”), a technology-focused holding company emphasizing the Internet of Things (“IoT”), announced today its entry into a material definitive agreement to acquire GeoTraq, Inc. from NASDAQ traded JanOne Inc. (NASDAQ: JAN). GeoTraq develops and manufactures entirely self-contained and ultra-small Mobile IoT (Internet of Things) modules for asset tracking, location-based services, and sensor modules for remote monitoring. The modules are plug-and-play and include turnkey connectivity to cloud services via GeoTraq’s proprietary cloud-based “WebTraq” platform. GeoTraq’s mission is to provide “Simple IoT” at a low cost, with ease of deployment, ease of use, and plug-and-play functionality with...

Table 1 Significant intercepts from Channel Sampling at the Voden target area, Iglika Project. Composites greater than 2 g/t are highlighted bold.Figure 1 Map of the Voden target area, located in the eastern portion of the Iglika License, showing results of previously disclosed soil sampling and new results of channel sampling undertaken in two areas, as well as the location of planned drill holesMineralized Channel Samples from the Voden Target include: 3.3m @ 12.14 g/t gold, including 1.0m @ 37.9 g/t gold,and 8.0m @ 1.79 g/t gold, including 3.0m @ 2.81 gold VANCOUVER, British Columbia, May 31, 2022 (GLOBE NEWSWIRE) — Velocity Minerals Ltd. (TSX.V: VLC) (“Velocity” or the “Company”) announces the commencement of drilling at the Voden gold exploration target (“Voden”), located in the Iglika project, Bulgaria (“Iglika” or...

–Phase 1 clinical trial will evaluate safety and immunogenicity of several formulations of SCB-2020S as a 2-dose vaccination series in adults– –SCB-2020S to further validate the use of Trimer-Tag™ as a plug-and-play technology platform and bolster Clover’s COVID-19 vaccine pipeline–  SHANGHAI, China, May 31, 2022 (GLOBE NEWSWIRE) — Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, today announced the first participants have been dosed in a Phase 1 clinical trial to assess the safety and immunogenicity of several formulations of SCB-2020S.   SCB-2020S is a second generation, potentially broadly protective COVID-19 vaccine candidate based on a chimeric Beta and prototype trimeric SARS-CoV-2 S-protein,...

Incap Corporation                 Press release         31 May 2022 at 3:30 p.m. EEST Incap Estonia invests in new production lines Incap Estonia is upgrading its two current SMT production lines and adding a third SMT line to its factory in Kuressaare. The new investment will increase the overall SMT production capacity by more than 50% and will be opened in the third quarter of this year. According to Greg Grace, Managing Director of Incap Estonia, the investment in two existing and one new SMT (surface-mount technology) line will help the company to support its growth and customer demands. Incap Estonia is investing EUR 1.35 million in a long-term lease agreement of six years by renting new production equipment from SMT Renting. “Technology is changing rapidly and therefore we have seen and experienced that the renting model suits our...

Vancouver, BC, May 31, 2022 (GLOBE NEWSWIRE) — Skyharbour Resources Ltd.’s (TSX-V: SYH) (OTCQB: SYHBF) (Frankfurt: SC1P) (the “Company”) partner company, Basin Uranium Corp. (“Basin Uranium”) is pleased to announce it has completed its phase one 2022 drill program at its Mann Lake project located 25 km southwest of the McArthur River Mine and 15 km to the northeast along strike of Cameco’s Millennium uranium deposit. The phase one program consisted of five holes totalling 3,503 metres with the unconformity being intersected between 608 metres to 651 metres in all holes. This was the first significant drill program undertaken on the property since 2007. The second phase of drilling is planned for the fall of this year and will consist of approximately 3,500 metres. Results from both the phase one drill program and upcoming geophysical...

MIAMI, May 31, 2022 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for the management of breast and prostate cancers, today announced that the Company will be presenting three presentations at the 2022 American Society of Clinical Oncology Annual Meeting which will be held in Chicago, IL from June 3-7, 2022. The presentations are: June 06, 2022: 8:00 AM – 11:00 AM – Session – Breast Cancer – MetastaticAbstract #TPS1121: Phase 3 ENABLAR-2 study to evaluate enobosarm and abemaciclib combination compared to estrogen blocking agent for the second line treatment of AR+ ER+ HER2- metastatic breast cancer in patients that have previously received palbociclib and estrogen blocking agent Presenter: Dr. Elgene...

Battery Innovation Center (BIC) conducted cell testing in May 2022 Mullen plans solid-state polymer battery cells for the second generation Mullen FIVE EV Crossover.Results from Indiana’s Battery Innovation Center (BIC) shows Mullen Automotive’s solid-state polymer battery cell testing exceeds previously stated values of 300 Ah (ampere-hour) at 3.7 volts. BIC testing shows impressive results of 343.28 Ah at 4.2 volts for Mullen’s solid-state polymer battery cell, which is in line with previously reported results from EV Grid. This data supports solid-state polymer battery cell technology, which when scaled to the vehicle pack level, and at a 150-kilowatt hour equivalent, can deliver over 600 miles of range on a full charge for the Mullen FIVE EV Crossover. BREA, Calif., May 31, 2022 (GLOBE NEWSWIRE) — via InvestorWire —...